Do you want to remove all your recent searches?

All recent searches will be deleted

Like
Watch Later
Share
Add to

(RTLX, IBIO, GVP) CRWENewswire Stocks In Action

6 years ago3 views

For the fourth quarter of 2011, Retalix Ltd - RTLX - posted total revenues of $62.5 million, a 16.2% increase year over year. GSE Systems Inc - GVP - announced new contracts valued at approximately $8.0 million involving nuclear, fossil, and process simulation, tutorials, and consulting services. Each of these projects was awarded during the first quarter of 2012. iBio Inc - IBIO - reported issuance of a US patent covering the use of iBio’s proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications.

*********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

Report this video

Select an issue

Embed the video

(RTLX, IBIO, GVP) CRWENewswire Stocks In Action
Autoplay
<iframe frameborder="0" width="480" height="270" src="//www.dailymotion.com/embed/video/xp58ek" allowfullscreen allow="autoplay"></iframe>
Add the video to your site with the embed code above